Enhabit (NYSE:EHAB – Get Free Report) and Selectis Health (OTCMKTS:GBCS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.
Valuation & Earnings
This table compares Enhabit and Selectis Health”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Enhabit | $1.06 billion | 0.65 | -$4.60 million | ($0.09) | -151.28 |
| Selectis Health | $39.49 million | 0.31 | -$2.42 million | ($0.27) | -15.00 |
Profitability
This table compares Enhabit and Selectis Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Enhabit | -0.43% | 4.71% | 2.23% |
| Selectis Health | -1.87% | N/A | -2.34% |
Analyst Ratings
This is a summary of current ratings for Enhabit and Selectis Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Enhabit | 1 | 6 | 2 | 0 | 2.11 |
| Selectis Health | 0 | 0 | 0 | 0 | 0.00 |
Enhabit presently has a consensus target price of $13.57, suggesting a potential downside of 0.32%. Given Enhabit’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Enhabit is more favorable than Selectis Health.
Volatility and Risk
Enhabit has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500. Comparatively, Selectis Health has a beta of -1.03, meaning that its share price is 203% less volatile than the S&P 500.
Summary
Enhabit beats Selectis Health on 10 of the 12 factors compared between the two stocks.
About Enhabit
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
About Selectis Health
Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
